Please login to the form below

Not currently logged in
Email:
Password:

BiondVax

This page shows the latest BiondVax news and features for those working in and with pharma, biotech and healthcare.

UK biotech Vaccitech raises £20m for universal flu shot

UK biotech Vaccitech raises £20m for universal flu shot

Israeli firm BiondVax has a two-dose candidate called M-001 in clinical development and said in December that it intends to start a phase III trial in the third quarter

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...

Infographics